Table 1.
tumour characteristics, treatment time, acute toxicity and early cosmetic results for all the patients treated at the 1.5 MRL.
| Patient | Laterality | Tumour location | T stage | Grade | Ki67 (%) | Mean in-room time (range, minutes) | Acute toxicity | Toxicity 3 months | Toxicity 1 year | Cosmesis 1 year |
|---|---|---|---|---|---|---|---|---|---|---|
| #1 | right | upper lateral | pT1c | 1 | 5 | 33.5 (25–44) | G1 breast edema, erythema, warm feeling, pain and fatigue | G1 breast edema | G1 breast oedema | good |
| #2 | left | upper central | pT1c | 2 | 5–10 | 26.2 (20–38) | G1 erythema and fatigue | none | none | excellent |
| #3 | left | upper lateral | pT1c | 1 | 10 | 26.9 (20–41) | G1 erythema, warm feeling and pain | G1 breast edema | G1 hyperpigmentation | good |
| #4 | right | lower medial | pT1c | 2 | 5 | 26.3 (20–32) | G2 breast edema, G1 erythema, warm feeling, pain and fatigue | G1 erythema, warm feeling and fatigue | none | good |
| #5 | right | upper medial | pT1c | 2 | 20 | 22.8 (19–29) | G1 erythema, warm feeling and pain | G1 hyperpigmentation | G1 hyperpigmentation | good |
| #6 | right | upper central | pT1a | 1 | 10 | 23.9 (21–33) | G2 breast edema, G1 erythema, pain and fatigue | G1 breast edema, erythema and warm feeling | none | excellent |
| #7 | right | upper lateral | pT1c | 2 | 5–10 | 22.9 (19–29) | G1 erythema | G1 erythema | G1 fibrosis | excellent |
| #8 | left | lower medial | pT1b | 2 | 15–20 | 25.1 (19–31) | G1 erythema, warm feeling, pain and fatigue | G1 hyperpigmentation, fibrosis and fatigue | none | excellent |
| #9 | right | upper lateral | pT1c | 1 | 5 | 23.5 (19–26) | G1 erythema and warm feeling | none | none | good |
| #10 | left | upper central | pT1c | 2 | 15–20 | 25.1 (20–33) | G1 erythema, warm feeling and pain | G1 edema; exanthema, in few days resolved | none | excellent |
| #11 | left | upper medial | pT1c | 2 | 10 | 27.3 (20–52) | G1 erythema, warm feeling and fatigue | none | none | excellent |